Zusammenfassung
Atemnot ist zusammen mit Schmerzen ein zentrales Problem von Patienten mit chronischen Erkrankungen im Endstadium. Palliative Therapie von Atemnot heißt nicht, Ätiologie und Pathogenese der Grundkrankheiten unberücksichtigt zu lassen. Der differenzierte und individualisierte Einsatz von technischen Hilfsmitteln und von Medikamenten hilft, Leiden zu verringern!
Abstract
Shortness of breath and pain are common problems in patients with end-stage chronic diseases. Palliative treatment of dyspnea does not mean that the etiology and pathogenesis of the diseases should not be taken into consideration. The differentiated and individualized application of technical aids and medication help to reduce suffering!
This is a preview of subscription content, log in via an institution to check access.
Literatur
Abernethy AP, McDonald CF, Frith PA et al (2010) Effect of palliative oxygen versus room air in the relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376:484
Booth S, Wade R, Johnson M et al (2004) The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 98:66
Cantin B, Rothuisen LE, Buclin T et al (2009) Referrals of cancer versus non-cancer patients to a palliative care consult team: do they differ? J Palliat Care 25:92
Clemens KE, Quednau I, Klaschik E (2008) Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med 11:204
Elkington H, White P, Addington-Hall J et al (2005) The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 19:485
Gärtner J, Simon S, Voltz R (2011) Palliativmedizin bei fortgeschrittenen inkurablen Erkrankungen. Internist 52:20
Jennings AL, Davies AN, Higgins JP et al (2002) A systematic review of the use of opioids in the management of dyspnoea. Thorax 57:939
Navigante AH, Castro MA, Cerchietti LC (2010) Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated. J Pain Symptom Manage 39:820
Simon ST, Higginson IJ, Booth S et al (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant disease in adults. Cochrane Database Syst Rev CD007354
Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advance cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31:58
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. Jürgen Fischer zum Abschied von seiner klinischen Tätigkeit.
Rights and permissions
About this article
Cite this article
Morr, H. Wenn uns der Atem am Ende verlässt. Somnologie 15, 212–214 (2011). https://doi.org/10.1007/s11818-011-0541-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11818-011-0541-x